January 24, 2018 / 11:05 AM / 4 months ago

BRIEF-Shire says FDA Approves Technology Transfer Of Cinryze Manufacturing Process To Vienna

Jan 24 (Reuters) - Shire Plc:

* FDA GRANTS APPROVAL TO SHIRE FOR TECHNOLOGY TRANSFER OF CINRYZE® DRUG PRODUCT MANUFACTURING PROCESS TO VIENNA, AUSTRIA MANUFACTURING SITE

* ‍SHIRE WILL BEGIN COMMERCIAL MANUFACTURING OF CINRYZE DRUG PRODUCT IN VIENNA IN Q1 OF 2018​

* ‍CINRYZE WILL ALSO CONTINUE TO BE PRODUCED BY A THIRD-PARTY SUPPLIER, PROVIDING AN ADDITIONAL SUPPLY SOURCE TO MEET PATIENT DEMAND.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below